Value of carotid intimal–medial thickness as independent predictor of endothelial dysfunction in uremic patients  by Younis, Hosni A. et al.
The Egyptian Heart Journal (2011) 63, 73–78Egyptian Society of Cardiology
The Egyptian Heart Journal
www.elsevier.com/locate/ehj
www.sciencedirect.comORIGINAL ARTICLEValue of carotid intimal–medial thickness as independent
predictor of endothelial dysfunction in uremic patientsHosni A. Younis a,*, Mohamed A. Nafady b, Mohamed Mahmoud ca Department of General Medicine, Faculty of Medicine, Al-Azhar Assiut University, Egypt
b Department of Radiology, Faculty of Medicine, Al-Azhar Assiut University, Egypt
c Department of Cardiology, Faculty of Medicine, Al-Azhar Assiut University, EgyptReceived 14 January 2011; accepted 26 February 2011
Available online 11 December 2011*
E
11
ho
Pe
doKEYWORDS
Intima media;
Endothelial dysfunction;
UremiaCorresponding author.
-mail address: a.7osny@yah
10-2608 ª 2011 Egyptian S
sting by Elsevier B.V. All rig
er review under responsibilit
i:10.1016/j.ehj.2011.09.008
Production and hoo.com (
ociety of
hts reser
y of Egyp
osting by EAbstract Background and aim of the work: Cardiovascular mortality and morbidity are signiﬁ-
cantly higher among uremic patients. Although the carotid intimal–medial thickness (C-IMT) as
a predictor of endothelial dysfunction (ED) has a prognostic value that has been well demonstrated
as an independent predictor of future cardiovascular events, its value in uremic patients need to be
re-assisted in our locality. The aim of the work is to investigate a correlation between the brachial
artery reactivity test (BART) and the carotid intimal–medial thickening (C-IMT) and their value as
independent predictors of endothelial dysfunction in uremic patients.
Subjects and methods: The study involved 70 uremic patients, 40 men and 30 women, 36–56 years
old, 40 of them on regular hemodialysis (HD) and 30 on conservative therapy, in addition to 30
healthy persons as a control group. They were selected from the General Medicine and Nephrology
Departments, Al-Azhar Assiut University and Assiut University Hospitals over a period of 2 years.
All of them were subjected to detailed history, thorough clinical examination, laboratory investiga-
tions including complete blood picture, renal function tests (urine analysis, blood urea, and serum
creatinine), lipid proﬁle, serum calcium and serum phosphorus, parathyroid hormone (PTH), fast-
ing blood glucose, electrocardiography (ECG), high resolution B-mode ultra-sonography for
C-IMT evaluation and brachial artery reactivity test (BART), and abdominal ultra-sonography.
Results: The results of the present study showed: (1) uremic patients are at an increased risk for
carotid atherosclerotic lesions, with signiﬁcant increase in C-IMT than controls with more signiﬁ-
cant increase in HD patients. (2) Uremic patients are characterized by impaired endotheliumH.A. Younis).
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74 H.A. Younis et al.dependent dilatation of the brachial artery (highly signiﬁcant reduction in ﬂow-mediated dilatation
(FMD%)), an abnormality related to the renal failure severity and to the hemodialysis doses. The
endothelial dysfunction in the brachial artery was more pronounced in HD patients than in patients
on conservative therapy. (3) Signiﬁcant positive correlation between increased C-IMT and reduc-
tion of the brachial FMD%. (4) Signiﬁcant relation between C-IMT and plaque prevalence and
HD duration, while no relations recorded between brachial FMD with HD duration.
Conclusion: (1) The study conﬁrmed that carotid IMT and brachial artery FMD can be used in
interventional studies in which cardiovascular risk is modiﬁed and increased in the uremic patients.
(2) There was negative correlation between brachial FMD and C-IMT in the uremic patients.
ª 2011 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Available evidence suggests that an excess risk of cardio-vascu-
lar disease (CVD) is present very early in the natural history of
chronic renal failure (CRF), which is still the major cause of
the morbidity and mortality in patients on conservative treat-
ment and in those on regular hemodialysis (HD).1 The in-
creased incidence of CVD in those patients is probably the
result of a high prevalence of both traditional and uremic risk
factors.2 In recent years, the role of non-traditional risk factors
has been highlighted. They include severe prolonged oxidative
stress, endothelial dysfunction, malnutrition, and chronic
inﬂammation.3 Abnormalities of endothelial function, and
hence vascular dysfunction, commence at an early age and pre-
cede the development of overt atherosclerosis.4 Celermajer
et al.4 standardized the brachial artery reactivity test (BART),
in which the endothelial function is assessed through a simple
non-invasive vascular ultrasonographic examination. The vas-
cular intimal–medial thickening (IMT) corresponds to the ini-
tial stage of atherosclerosis, preceding plaque formation.5 The
aim of the work is to investigate a correlation between the bra-
chial artery reactivity test (BART) and carotid intimal–medial
thickening (C-IMT) and their value as independent predictors
of endothelial dysfunction in uremic patients on conservative
treatment or on regular hemodialysis.2. Subjects and methods
2.1. Subjects
This study involved 70 patients with chronic renal failure, 40
men and 30 women, 36–56 years old. They were divided into
two groups. Group-A: included 40 uremic patients on regular
HD. The duration of HD was 3–84 months. Group-B: in-
cluded 30 uremic patients on conservative treatment in addi-
tion to 30 healthy sex and age matched controls (group-C).
Informed consent was obtained from each subject in the study.
They were selected from Internal Medicine and Nephrology
Departments of Al-Azhar Assuit University and Assuit Uni-
versity Hospitals from November 2007 to 2009.
2.2. Methods
All selected subjects were subjected to the following:
(1) Thorough history and full clinical examination. (2) Rest-
ing 12 leads ECG. (3) Lab. investigations including: completeblood picture, renal function tests (urine analysis, blood urea,
and serum creatinine), lipid proﬁle, serum calcium and phos-
phorus, parathyroid hormone (PTH), and fasting blood
glucose.
(4) Radiological studies including: abdominal ultra-sonog-
raphy, measurement of the carotid artery intimal–medial
thickening (C-IMT) and brachial artery reactivity test
(BART). The radiological studies used high-resolution B-mode
ultrasound machine (GE general electric LOGIQ9) and
7.5–10 MHz high resolution linear array transducer. Single
highly qualiﬁed experienced ultrasonographist physician una-
ware of the clinical and laboratory data, examined all the sub-
jects of different groups to minimize operator variability. The
study was performed according to the technique described in
the previous studies of Fathi and Marwick6 and Moens
et al.7 The carotid arteries were examined bilaterally in the
areas of the common carotid artery, the carotid bifurcation
and the internal carotid artery on the left and right sides.
The wall of the common carotid artery is thicker and produces
two distinct echoes. The space between the echoes represents
the actual vessel wall intima–media thickness which measures
normally 0.05 cm thick in the common carotid artery. Each
carotid wall and segment was examined independently from
continuous angles to identify the thickest intimal–medial site
of the far wall and in the plaques free area. Endothelial inde-
pendent dilatation was measured by a calculation of the
vasodilator response to exogenous nitrate 3 min after adminis-
tration of 5 mg of sublingual nitroglycerine. The percent diam-
eter changes for FMD and nitrate- mediated dilatation was
calculated in relation to its respective rest scan.
Microsoft ofﬁce excel 2007 was used for the analysis of col-
lected data and they were presented as mean ± standard
deviations.3. Results
– The frequency of the traditional CV risk factors increased in
both patients groups (A and B) than controls (C) (Table 1).
– Carotid duplex scanning showed that the carotid IMT is sig-
niﬁcantly thicker in patients groups (groups A and B, more
in HD group) than controls (group C) (Table 2 and Fig. 1).
– The frequency of both types of vascular plaques is signiﬁ-
cantly increased in both patient groups than controls (Table
3 and Fig. 2).
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Table 1 Frequency of traditional CV risk factors in the
studied groups.
Group A Group B
No. % No. %
Diabetes mellitus 13 32.5 9 30
Hypertension 9 22.5 6 20
Dyslipidemia 8 20 5 16.66
Coronary A disease 8 20 5 16.66
LV hypertrophy 25 62.5 15 50
Cerebro-vascular artery 3 7.5 1 3.33
Table 3 Plaque frequency in the studied groups.
Group A Group B q Value
No. % No. %
A
Plaque 24 60 17 56.66 0.011*
Soft plaque 9 22.5 8 26.66 0.067(NS)
Calciﬁed plaque 15 37.5 9 30 0.001***
B
Plaque 24 60 6 20 0.001***
Soft plaque 9 22.5 5 16.66 0.012*
Calciﬁed plaque 15 37.5 1 3.33 0.0001***
C
Plaque 17 56.66 6 20 0.002**
Soft plaque 8 26.66 5 16.66 0.051(NS)
Calciﬁed plaque 9 30 1 3.33 0.003**
NS, non-signiﬁcant.
* Signiﬁcant.
** Highly signiﬁcant.
*** Very highly signiﬁcant.
Value of carotid intimal–medial thickness as independent predictor of endothelial dysfunction in uremic patients 75– Regarding BART: brachial artery FMD is signiﬁcantly
reduced in patient groups (more in HD patients) than in
controls (Table 3 and Fig. 3). While the nitroglycerin med-
iated dilatation (NMD%), no signiﬁcant difference among
all groups was observed (Table 3 and Fig. 4).
– The study revealed:
(A) Signiﬁcant positive correlation between carotid artery
intimal–medial thickening (C-IMT) and age (Fig. 5).
(B) Signiﬁcant positive correlation between C-IMT and
creatinine (Fig. 6).
(C) Signiﬁcant positive correlation between C-IMT and
FMD% reduction (Fig. 7).
(D) Signiﬁcant positive correlation between C-IMT and
triglyceride (Fig. 8).0
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Figure 1 IMT in different groups.4. Discussion
Endothelial dysfunction (an important phenomenon in athero-
genesis) contributes to the progression of atherosclerosis in pa-
tients with renal failure, which is not corrected by HD.8
Carotid artery IMT is an independent predictor of CV mortal-
ity in HD patients, so it is usefully applied for risk stratiﬁca-
tion in the dialysis population.9 High-resolution echo color
Doppler ultrasonography is a non-invasive, reliable, andTable 2 Comparative measures of IMT, FMD, and NMD.
Group A Group B q Value
Mean S.D. Mean S.D.
A
IMT 1.14 0.26223 1.062 0.22024 0.003**
FMD 8.52 2.92499 13.33 1.44561 0.002**
NMD 16.77 3.16495 16.93 2.02313 0.067 (NS)
B
IMT 1.14 0.26223 0.58 0.10845 0.001***
FMD 8.52 2.92499 16.02 2.97581 0.003**
NMD 16.77 3.16495 17.12 3.68945 0.784 (NS)
C
IMT 1.062 0.22024 0.58 0.10845 0.001***
FMD 13.33 1.44561 16.02 2.97581 0.011**
NMD 16.93 2.02313 17.12 3.68945 0.129 (NS)
NS, non-signiﬁcant.
*Signiﬁcant.
** Highly signiﬁcant.
*** Very highly signiﬁcant.
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Figure 2 The frequency of plaque types.reproducible method for detecting and monitoring the progres-
sion of preclinical atherosclerosis.10 The association of endo-
thelial dysfunction with renal failure has previously been
demonstrated in the brachial artery of pre-dialysis children
and in the forearm microcirculation of uremic adults.11
In the current study, we found a signiﬁcant difference in C-
IMT and plaques, as markers of atherosclerosis among HD
patients and controls, which is in agreement with many stud-
ies.10,12 They found extensive remodeling of a ‘‘vascular tree’’
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Figure 3 FMD of the groups.
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Figure 4 NMD of the groups.
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Figure 5 Correlation between C-IMT and age (r=+0.968).
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Figure 6 Correlation between creatinine and C-IMT
(r=+0.98).
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Figure 7 Correlation between C-IMT and FMD% reduction
(r= 0.958).
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Figure 8 Correlation between C-IMT and TGD (r=+0.816).
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CVD complications reported in ESRD. Also, we found a sig-
niﬁcant increase in C-IMT in HD patients more than in uremic
patients on conservative treatment and this may be attributed
to the effect of HD per se as independent risk factor for accel-
erated atherosclerosis. This is in agreement with the study of
Benedetto et al.13
In our study, we found that carotid plaques were signiﬁ-
cantly prevalent in HD patients (60%) and in patients on con-
servative treatment (56.66%) more than in healthy controls
(20%). Also, calciﬁed plaques were more prevalent in uremic
patient whether on HD (37.5%) or on conservative treatment
(30%) in comparison with controls (3.3%). This is in agree-
ment with many related studies14.
Our results conﬁrmed the presence of impaired endothe-
lium-dependent vasodilatation in the brachial artery of uremic
adults. Serum creatinine showed signiﬁcant negative correla-
tion with FMD in uremic patients, suggesting that endothelial
dysfunction is probably associated with the development of re-
nal insufﬁciency. HD patients showed further FMD impair-
ment, while the response to nitroglycerin has no difference
compared either to uremic patients or to healthy controls, this
indicates a more pronounced endothelial dysfunction in the
brachial artery on HD patients. This is in accordance with
many related studies.15,16 They revealed that the brachial
Value of carotid intimal–medial thickness as independent predictor of endothelial dysfunction in uremic patients 77artery FMD in uremic patients (on HD or on conservative
treatment) was reduced compared to controls. While endothe-
lium-independent response to glyceryl tri-nitrate was similar in
the two patient groups compared with healthy controls. Also,
Karakitsos et al.17 study resulted in a signiﬁcant increase in
C-IMT and plaque prevalence and reduced brachial artery
FMD and NMD in ESRD patients on HD. The increased inci-
dence of CVD in ESRD patients is probably the result of high
prevalence of both traditional and non-traditional risk factors.
HD patients have some uremia-related CV risk factors.
Age is a risk factor for atherosclerosis in general population.
Our study showed a signiﬁcant correlation between age and
C-IMT values and the presence of plaque. This result showed
that age is also an independent risk factor for atherosclerosis
in uremic patient whether on conservative treatment or on
HD. This is in agreement with the studies of Magyar et al.18
and Brzosko et al.10 However, this contradicts with Burdick
et al.19, who found no correlation between carotid IMT and
the age of the uremic patients and the control subjects and this
may be because of the fact that the mean age of the patients in
our study was higher than that in their study. In our study, a
signiﬁcant negative correlation was seen between age and bra-
chial artery FMD of both patients on conservative treatment
and those on HD which is in accordance with Ghiadoni et al.20
In our study, the serum creatinine of uremic patients was
signiﬁcantly positively correlated with carotid IMT and inver-
sely correlated with FMD%. It is very likely that the greater
and presumably the longer renal function derangement could
lead to a more severe abnormality of the endothelium-depen-
dent vasodilatation in HD patients.16
In the current study, the C-IMT and the prevalence of the
carotid plaques were signiﬁcantly correlated with the duration
of HD (patients on HD). This is in agreement with Grekas
et al.21 and Delucchi et al.22
The Nakashima’s23 study found no signiﬁcant correlation
between the IMT and the duration of HD. In this context,
some previous studies have suggested that carotid atheroscle-
rosis might be accelerated by the uremic state present rather
than by hemodialysis (Kawagishi et al.).24
5. Conclusions and recommendations
1. The study conﬁrmed that high-resolution B-mode ultra-
sound is a useful and non-invasive technique which allows
the uremic patient to be checked repeatedly during the
treatment for protection from CVD events.
2. There was negative correlation between brachial artery
FMD and carotid IMT in the uremic patients.
3. Carotid IMT and brachial artery FMD and NMD as valid
surrogate end points can also be used in intervention stud-
ies in which cardiovascular risk factors are modiﬁed in the
uremic population.
4. Interventional strategies leading to reversal of endothelial
dysfunction in humans are highly recommended in uremic
patients such as: (A) general interventions (physical activ-
ity, smoking cessation, lipid-lowering therapy, and glycemic
control of diabetes). (B) Pharmaceuticals (angiotensin con-
verting enzyme inhibitors, angiotensin receptor blockers,
statins, peroxisome proliferator-activated receptor-cactivators, and estrogens), (C) Dietary supplements (n-3
fatty acids, folate, tetrahydrobiopterin, L-arginine, vitamin
C, vitamine E, and dietary ﬂavonoids).
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